Connection

Mark Hamner to Antidepressive Agents

Back to Details
This is a "connection" page, showing publications Mark Hamner has written about Antidepressive Agents.
Mark Hamner
Connection Strength
0.974
Antidepressive Agents
  1. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun; 21(2):89-94.
    View in: PubMed
    Score: 0.282
  2. Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectr. 2004 Oct; 9(10):740-52.
    View in: PubMed
    Score: 0.206
  3. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161.
    View in: PubMed
    Score: 0.177
  4. Buspirone potentiation of antidepressants in the treatment of PTSD. Depress Anxiety. 1997; 5(3):137-9.
    View in: PubMed
    Score: 0.121
  5. Discontinuation of antidepressant medications before ECT. Convuls Ther. 1996 Jun; 12(2):125-6.
    View in: PubMed
    Score: 0.116
  6. Cortisol awakening response in PTSD treatment: Predictor or mechanism of change. Psychoneuroendocrinology. 2020 08; 118:104714.
    View in: PubMed
    Score: 0.038
  7. Recurrent psychotic depression associated with GM2 gangliosidosis. Psychosomatics. 1998 Sep-Oct; 39(5):446-8.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.